Intensive Care Medicine

, Volume 33, Issue 7, pp 1155–1161

Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients

  • Antonella Agodi
  • Martina Barchitta
  • Rosalba Cipresso
  • Loredana Giaquinta
  • Maria Antonietta Romeo
  • Carmelo Denaro
Original

Abstract

Objective

We evaluated whether Pseudomonas aeruginosa associated nosocomial infections in our ICU originate mainly from patients' endogenous flora or from exogenous cross-transmission.

Design and setting

A 6-month prospective surveillance survey was performed according to standardized protocols at the interdisciplinary ICU of the Azienda Ospedaliera Cannizzaro.

Patients

The study analyzed 121 patients and focused on three different states: carriage upon admission, colonization of sterile sites, and infections during ICU stay.

Results

We identified 138 P. aeruginosa isolates from 45 patients. The cumulative incidence of P. aeruginosa sustained colonization in the ICU was 29.9/100 patients, and the incidence density was 16.2/1,000 patient-days. The cumulative incidence of P. aeruginosa-sustained infections in the ICU was 36.7/100 patients, and the incidence density was 19.9/1,000 patient-days. The most frequent infection type was ventilator-associated pneumonia. PFGE analysis of P. aeruginosa isolates led to the identification of a major clone represented by 60.8% of isolates involving 45.9% of patients. The impact of cross-transmission, i.e., the preventable proportion of P. aeruginosa acquisition, was estimated to be at least 59.5% of all colonization or infection episodes. Acquisition of multidrug-resistant P. aeruginosa was significantly associated with cross-transmission.

Conclusions

Our results suggest that the ICU personnel and environment served as reservoirs for cross-transmission and emphasize the importance of exogenous acquisition of multidrug-resistant P. aeruginosa, of reduction in antibiotic pressure, and prompt enforcement of infection control measures.

Keywords

Pulmonary nosocomial infections Pseudomonas aeruginosa Multidrug resistance Surveillance Colonization Carriage 

References

  1. 1.
    Burke JP (2003) Infection control–a problem for patient safety. N Engl J Med 348:651–656PubMedCrossRefGoogle Scholar
  2. 2.
    Wenzel RP, Thompson RL, Landry SM (1983) Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control 4:371–375PubMedGoogle Scholar
  3. 3.
    Grundmann H, Barwolff S, Tami A, Behnke M, Schwab F, Geffers C, Halle E, Gobel UB, Schiller R, Jonas D, Klare I, Weist K, Witte W, Beck-Beilecke K, Schumacher M, Ruden H, Gastmeier P (2005) How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 33:946–951PubMedCrossRefGoogle Scholar
  4. 4.
    Trautmann M, Lepper PM, Haller M (2005) Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am J Infect Control 33:41–49CrossRefGoogle Scholar
  5. 5.
    Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644PubMedCrossRefGoogle Scholar
  6. 6.
    Vincent JL (2000) Microbial resistance: lessons from the EPIC study. European prevalence of infection. Intensive Care Med 26(Suppl 1):S3–S8PubMedCrossRefGoogle Scholar
  7. 7.
    Glupczynski Y, Delmee M, Goossens H, Struelens MJ (2001) Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units (ICU) in Belgian hospitals between 1996 and 1999. Acta Clin Belg 56:297–306PubMedGoogle Scholar
  8. 8.
    Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP (2004) Emerging resistance among bacterial pathogens in the intensive care unit–a European and North American Surveillance study (2000–2002). Ann Clin Microbiol Antimicrob 3:14PubMedCrossRefGoogle Scholar
  9. 9.
    Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH, VAP Outcomes Scientific Advisory Group (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2115–2121PubMedCrossRefGoogle Scholar
  10. 10.
    Bertrand X, Thouverez M, Talon D, Boillot A, Capellier G, Floriot C, Helias JP (2001) Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med 27:1263–1268PubMedCrossRefGoogle Scholar
  11. 11.
    Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y (2006) Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother 50:43–48PubMedCrossRefGoogle Scholar
  12. 12.
    Deplano A, Denis O, Poirel L, Hocquet D, Nonhoff C, Byl B, Nordmann P, Vincent JL, Struelens MJ (2005) Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 43:1198–1204PubMedCrossRefGoogle Scholar
  13. 13.
    Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD (2003) Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 31:208–215PubMedGoogle Scholar
  14. 14.
    Agodi A, Barchitta M, Giaquinta L, Romeo MA, Denaro C (2006) Pseudomonas aeruginosa infection in ICU patients: highlighting the silent epidemic. Clin Microbiol Infect 12 (Suppl 4):P1022Google Scholar
  15. 15.
    Hospital In Europe Link For Infection Control Through Surveillance (2004) Surveillance of nosocomial infections in intensive care units. Protocol version 6.1, September; available at: http://Helics.Univ-Lyon1.Fr/
  16. 16.
    Horan TC, Emori TG (1997) Definitions of key terms used in the NNIS System. Am J Infect Control 25:112–116PubMedCrossRefGoogle Scholar
  17. 17.
    National Nosocomial Infections Surveillance System (2004) Report: data summary from January 1992 through June 2004. Am J Infect Control 32:470–485CrossRefGoogle Scholar
  18. 18.
    National Committee for Clinical Laboratory Standards (2002) Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 5th edn. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.Google Scholar
  19. 19.
    Meyer E, Schwab F, Jonas D, Rueden H, Gastmeier P, Daschner FD (2004) Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units (SARI): I. Antimicrobial use in German intensive care units. Intensive Care Med 30:1089–1096PubMedCrossRefGoogle Scholar
  20. 20.
    Jung R, Fish DN, Obritsch MD, MacLaren R (2004) Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect 57:105–111PubMedCrossRefGoogle Scholar
  21. 21.
    Anonymous (1999) ATC index with DDDs WHO collaborating centre for drug statistics methodology. WHO, OsloGoogle Scholar
  22. 22.
    Agodi A (2000) Sistemi di tipizzazione epidemiologica dei microrganismi responsabili di infezioni in ospedale: uso e valutazione. Ann Ig 12:41–46PubMedGoogle Scholar
  23. 23.
    Struelens M (1996) Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect 2:2–11PubMedGoogle Scholar
  24. 24.
    Tenover F, Arbeit R, Goering R (1997) How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Infect Control Hosp Epidemiol 18:426–439PubMedCrossRefGoogle Scholar
  25. 25.
    Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239PubMedGoogle Scholar
  26. 26.
    Weist K, Pollege K, Schultz I, Ruden H, Gastmeier P (2002) How many nosocomial infections are associated with cross-transmission? A prospective cohort study in a surgical intensive care unit. Infect Control Hosp Epidemiol 23:127–132PubMedCrossRefGoogle Scholar
  27. 27.
    Bergmans DC, Bonten MJ, van Tiel FH, Gaillard CA, van der Geest S, Wilting RM, de Leeuw PW, Stobberingh EE (1998) Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit. Thorax 53:1053–1058PubMedCrossRefGoogle Scholar
  28. 28.
    Cattoen C, Levent T, Granbastien B, Descamps D, Bouillet L, Coignard B, Beaucaire G, reseau de microbiologists de l'ARECLIN (1999) Observatoire regional Pseudomonas aeruginosa du Nord Pas de Calais: donnèes epidemiologiques et microbiologiques. Med Mal Infect 29:160–166CrossRefGoogle Scholar
  29. 29.
    Langer M, Carretto E, Haeusler EA (2001) Infection control in ICU: back (forward) to surveillance samples? Intensive Care Med 27:1561–1563PubMedCrossRefGoogle Scholar
  30. 30.
    Mikolajczyk RT, Sagel U, Bornemann R, Kramer A, Kretzschmar M (2007) A statistical method for estimating the proportion of cases resulting from cross-transmission of multi-resistant pathogens in an intensive care unit. J Hosp Infect 65:149–155PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Antonella Agodi
    • 1
    • 2
    • 3
  • Martina Barchitta
    • 1
    • 2
  • Rosalba Cipresso
    • 1
  • Loredana Giaquinta
    • 4
  • Maria Antonietta Romeo
    • 4
  • Carmelo Denaro
    • 4
  1. 1.Department of Biomedical SciencesUniversity of CataniaCataniaItaly
  2. 2.Gruppo Italiano Studio Igiene OspedalieraCataniaItaly
  3. 3.Laboratorio di progettazione sperimentazione e analisi di politiche pubbliche e servizi alle personeUniversity of CataniaCataniaItaly
  4. 4.Intensive Care UnitAzienda Ospedaliera CannizzaroCataniaItaly

Personalised recommendations